Champions Oncology (CSBR) Gross Profit (2010 - 2026)

Champions Oncology's Gross Profit history runs 17 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Gross Profit rose 33.3% year-over-year to $13.9 million; the TTM figure through Jan 2026 stood at $38.9 million (down 26.01% YoY), while the FY2025 annual figure was $28.6 million, down 33.73% from the prior year.
• Gross Profit was $13.9 million for Q1 2026 at Champions Oncology, up from $7.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $29.1 million in Q2 2024 to a low of -$6.0 million in Q2 2022.
• Historically, Gross Profit has averaged $8.7 million across 5 years, with a median of $7.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit slumped 165.89% in 2022, then soared 407.4% in 2024.
• A 5-year view of Gross Profit shows it stood at $6.8 million in 2022, then dropped by 27.54% to $5.0 million in 2023, then grew by 22.32% to $6.1 million in 2024, then grew by 28.25% to $7.8 million in 2025, then soared by 78.73% to $13.9 million in 2026.
• The last three Gross Profit figures came in at $13.9 million (Q1 2026), $7.8 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.